- Merck's 5% Q3 revenue growth lags Eli Lilly's 39%, driven by obesity drugs Mounjaro and Zepbound. - Merck MRK-- faces "Keytruda cliff" risks as its flagship drug nears 2028 U.S. patent expiry, with ...

Click on an indicator below to add it to the chart.

FRANKFURT (dpa-AFX) - Investors reacted positively on Thursday to Adidas' detailed quarterly figures. Around midday, the shares led the firm Dax index, gaining nearly four percent. They reached €165 ...

Data delayed at least 15 minutes, as of Oct 26 2026 20:00 BST.

Private-sector spending on artificial intelligence has accounted for roughly half of U.S. economic growth since the start of ...

Real GDP increased at a 3.4% annual rate over the last three months, up from 2.2% in the second quarter, the Commerce ...

Meta's Binance tokenized futures contract is trading at $621.81, below every tracked moving average and with momentum ...

Eli Lilly’s shares rose 4% in early morning trading after reporting revenue of $24.4 billion, well past consensus estimates.

US economic growth accelerated last quarter at its fastest pace in over a year; however, rising gas prices helped to lift inflation in September to a four-month high, new data showed Thursday.

Truth be told, I dabbled a bit in computational complexity theory back in my student days, and looking back on it now, I can ...

OpenAI's AI refuted the Exponential Time Hypothesis. See why P vs NP still stands and Bitcoin's cryptography stays safe.

On October 26, OpenAI published a 67-page paper titled "The Exponential Time Hypothesis is False." The following day, the ...